Selected Publications
Tadrous PJ, Siegel J, French PM, Shousha S, Lalani el-N, Stamp GW. Fluorescence lifetime imaging of unstained tissues: early results in human breast cancer. J Pathol. 2003; 199(3): 309-317.
Morita M, Stamp G, Robins P, Dulic A, Rosewell I, Hrivnak G, Daly G, Lindahl T, Barnes DE. Gene-targeted mice lacking the Trex1 (DNase III) 3'-->5' DNA exonuclease develop inflammatory myocarditis. Mol Cell Biol. 2004; 24(15): 6719-6727.
Brown MA, Nicolai H, Howe K, Katagiri T, Lalani el-N, Simpson KJ, Manning NW, Deans A, Chen P, Khanna KK, Wati MR, Griffiths BL, Xu CF, Stamp GW, Solomon E. Expression of a truncated Brca1 protein delays lactational mammary development in transgenic mice. Transgenic Res. 2002; 11(5): 467-478.
Denzel A, Molinari M, Trigueros C, Martin JE, Velmurgan S, Brown S, Stamp G, Owen MJ. Early postnatal death and motor disorders in mice congenitally deficient in calnexin expression. Mol Cell Biol. 2002; 22(21): 7398-7404.
Lalani EN, Williams R, Jayaram Y, Gilbert C, Chaudhary KS, Siu LS, Koumarianou A, Playford R, Stamp GW. Trefoil factor-2, human spasmolytic polypeptide, promotes branching morphogenesis in MCF-7 cells. Lab Invest. 1999; 79(5): 537-546.
Primary Research Publications
2006
Pollard PJ, El-Bahrawy M, Poulsom R, Elia G, Killick P, Kelly G, Hunt T, Jeffery R, Seedhar P, Barwell J, Latif F, Gleeson MJ, Hodgson SV, Stamp GW, Tomlinson IPM, Maher ER. Expression of HIF-1α, HIF-2α(EPAS1), and their target genes in paraganglioma and phaeochromocytoma with VHL and SDH mutations. Journal of Clinical Endocrinology and Metabolism 2006; 91: 4593-4598
Punjabi S, Wright C, Teixeira F, Stamp G, Chu A. Intraepidermal animal-type melanoma. International Journal of Dermatology 2006; 45: 957-959
Rosenfelder NA, Taylor-Robinson SD, Jackson JE, Stamp GW. Segmental mediolytic arteriopathy in a patient with intraperitoneal bleeding. European Journal of Gastroenterology and Hepatology 2006; 18: 295-297
Spencer-Dene B, Sala FG, Bellusci S, Gschmeissner S, Stamp G, Dickson C. Stomach development is dependent on fibroblast growth factor 10/fibroblast growth factor receptor 2b-mediated signaling. Gastroenterology 2006; 130: 1233-1244
Thompson EL, Murphy KG, Patterson M, Bewick GA, Stamp GWH, Curtis AE, Cooke JH, Jethwa PH, Todd JF, Ghatei MA, Bloom SR. Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats. American Journal of Physiology-Endocrinology and Metabolism 2006; 291: E1074-E1082
Verheijen RH, Massuger LF, Benigno BB, Epenetos AA, Lopes A, Soper JT, Markowska J, Vyzula R, Jobling T, Stamp G, Spiegel G, Thurston D, Falke T, Lambert J, Seiden MV. Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission. Journal of Clinical Oncology 2006; 24: 571-578
Other Publications
Naresh KN, Lampert I, Hasserjian R, Lykidis D, Elderfield K, Horncastle D, Smith N, Murray-Brown W, Stamp GW. Optimal processing of bone marrow trephine biopsy: the Hammersmith Protocol. Journal of Clinical Pathology 2006; 59: 903-911
